The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphoma

Danielle BongeroCenter for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, NY, USA

Luca PaoluzziCenter for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, NY, USA

Enrica MarchiCenter for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, NY, USA

Kelly M. ZulloCenter for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, NY, USA

Roberto NeisaDepartment of Pathology, Columbia University Medical Center, NY, USA

Yinghui MaoDepartment of Pathology, Columbia University Medical Center, NY, USA

Rafael EscandonCytokinetics, South San Francisco, CA, USA

Ken WoodCytokinetics, South San Francisco, CA, USA

Owen A. O’ConnorCenter for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, NY, USACorrespondence[email protected]

Your download is now in progress and you may close this window